Growth Metrics

NeuroPace (NPCE) Cost of Revenue (2020 - 2026)

NeuroPace has reported Cost of Revenue over the past 7 years, most recently at $4.0 million for Q1 2026.

  • For Q1 2026, Cost of Revenue fell 63.46% year-over-year to $4.0 million; the TTM value through Mar 2026 reached $32.9 million, up 156.0%, while the annual FY2025 figure was $46.6 million, 123.72% up from the prior year.
  • Cost of Revenue for Q1 2026 was $4.0 million at NeuroPace, down from $10.9 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $12.6 million in Q3 2025 and troughed at -$8.9 million in Q4 2024.
  • A 5-year average of $4.8 million and a median of $4.5 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: crashed 299.17% in 2024 and later soared 222.92% in 2025.
  • Year by year, Cost of Revenue stood at $4.0 million in 2022, then increased by 12.07% to $4.5 million in 2023, then crashed by 299.17% to -$8.9 million in 2024, then soared by 222.92% to $10.9 million in 2025, then tumbled by 63.24% to $4.0 million in 2026.
  • Business Quant data shows Cost of Revenue for NPCE at $4.0 million in Q1 2026, $10.9 million in Q4 2025, and $12.6 million in Q3 2025.